Bringing this thread back to topic.
My head is still spinning that Justaposer said that because Starpharma were appealing/talking to the FDA to try to overturn the negative VivaGel decision, and because the chairman has been buying shares, this was somehow evidence that Starpharma are going to seek or were already in the process of seeking accelerated approval for DEP in cancer indications.
Holy heck, what !? Can I please have what he’s having? Must be a decent trip.
I seem to remember that Justaposer also believed adamantly that DEP-Dudetaxel was going to alter the cancer treatment landscape. Instead it’s basically been shelved.
Good one.
- Forums
- ASX - By Stock
- SPL
- Accelerated Approval?
Accelerated Approval?, page-25
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.1¢ |
Change
0.001(0.56%) |
Mkt cap ! $37.11M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 9.0¢ | $25.27K | 279.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 89000 | 9.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.1¢ | 1908 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 89000 | 0.090 |
1 | 127200 | 0.087 |
3 | 61395 | 0.086 |
2 | 76000 | 0.085 |
1 | 32500 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 1908 | 1 |
0.093 | 65000 | 1 |
0.095 | 40000 | 1 |
0.097 | 50000 | 1 |
0.099 | 1285 | 1 |
Last trade - 10.23am 15/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online